Quante M, Dietrich A, ElKhal A, Tullius S G
1] Division of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA [2] IFB Integrated Research and Treatment Centre Adiposity Diseases, University of Leipzig, Leipzig, Germany [3] Department of Visceral, Transplantation, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.
1] IFB Integrated Research and Treatment Centre Adiposity Diseases, University of Leipzig, Leipzig, Germany [2] Department of Visceral, Transplantation, Thoracic and Vascular Surgery, University Hospital Leipzig, Leipzig, Germany.
Int J Obes (Lond). 2015 Jun;39(6):877-83. doi: 10.1038/ijo.2015.21. Epub 2015 Feb 20.
The obesity epidemic represents a critical disease burden with broad clinical consequences. At the same time, obesity has been linked to inferior surgical outcomes and considered a contraindication for some elective surgical procedures. A growing body of mechanistic evidence has accumulated linking obesity to changes of metabolism and immune responses. This concept provides an integrated inflammatory network based on the perception of obesity as a state of chronic low-grade inflammation. With a more detailed understanding of this dynamic network and mechanistic insights, novel treatment and management strategies may be developed with the goal to optimize surgical outcomes in obese patients.
肥胖流行是一种具有广泛临床后果的严重疾病负担。与此同时,肥胖与较差的手术结果相关联,并被视为一些择期手术的禁忌证。越来越多的机制性证据表明肥胖与代谢和免疫反应的变化有关。这一概念基于将肥胖视为一种慢性低度炎症状态,提供了一个综合的炎症网络。随着对这个动态网络的更详细理解和机制性见解的深入,可能会开发出新的治疗和管理策略,目标是优化肥胖患者的手术结果。